This menu provides the list of EV miRNAs identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Maximum false positive rate (FPR): Maximum true positive rate (TPR):
  - FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
  - TPR is the percentile of miRNA among the present miRNAs.
    Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.

Mature name miRBase accession FPR TPR Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-629-3pMIMAT0003298 3.0e-13 4.7e-1Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits.
Mol Cancer. 2012 Jun 8;11:37. doi: 10.1186/1476-4598-11-37.		MIPF0001555_218 / 0 / 18
hsa-miR-629-3pMIMAT0003298 7.9e-9 4.8e-1Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits.
Mol Cancer. 2012 Jun 8;11:37. doi: 10.1186/1476-4598-11-37.		MIPF0001555_218 / 0 / 18
hsa-miR-629-3pMIMAT0003298 2.2e-5 5.0e-1Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits.
Mol Cancer. 2012 Jun 8;11:37. doi: 10.1186/1476-4598-11-37.		MIPF0001555_218 / 0 / 18
hsa-miR-629-3pMIMAT0003298 4.9e-9 4.7e-1Identifying mRNA, microRNA and protein profiles of melanoma exosomes.
PLoS One. 2012;7(10):e46874. doi: 10.1371/journal.pone.0046874. Epub 2012 Oct 9.		MIPF0001555_218 / 0 / 18
hsa-miR-629-3pMIMAT0003298 0.0e+0 3.7e-1microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy.
Hum Reprod. 2013 Jun;28(6):1455-67. doi: 10.1093/humrep/det088. Epub 2013 Mar 28.		MIPF0001555_218 / 0 / 18
hsa-miR-629-3pMIMAT0003298 0.0e+0 3.5e-1microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy.
Hum Reprod. 2013 Jun;28(6):1455-67. doi: 10.1093/humrep/det088. Epub 2013 Mar 28.		MIPF0001555_218 / 0 / 18
hsa-miR-629-3pMIMAT0003298 0.0e+0 3.5e-1microRNA signature is altered in both human epididymis and seminal microvesicles following vasectomy.
Hum Reprod. 2013 Jun;28(6):1455-67. doi: 10.1093/humrep/det088. Epub 2013 Mar 28.		MIPF0001555_218 / 0 / 18
hsa-miR-629-3pMIMAT0003298 0.0e+0 2.9e-1Circulating exosomal microRNAs as biomarkers of colon cancer.
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.		MIPF0001555_218 / 0 / 18
hsa-miR-629-3pMIMAT0003298 1.1e-3 1.1e-3Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.		MIPF0001555_218 / 0 / 18
hsa-miR-629-3pMIMAT0003298 6.6e-9 0.0e+0Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.
Blood. 2014 Oct 15. pii: blood-2014-05-576116.		MIPF0001555_218 / 0 / 18
hsa-miR-629-3pMIMAT0003298 1.2e-5 4.8e-1Combined Evaluation of a Panel of Protein and miRNA Serum Exosome Biomarkers for Pancreatic Cancer Diagnosis Increases Sensitivity and Specificity.
Int J Cancer. 2014 Nov 12. doi: 10.1002/ijc.29324.		MIPF0001555_218 / 0 / 18
hsa-miR-629-3pMIMAT0003298 0.0e+0 2.5e-1Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0001555_218 / 0 / 18
hsa-miR-629-3pMIMAT0003298 0.0e+0 4.1e-1Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0001555_218 / 0 / 18
hsa-miR-629-3pMIMAT0003298 0.0e+0 3.5e-1Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0001555_218 / 0 / 18
hsa-miR-629-3pMIMAT0003298 0.0e+0 2.1e-1Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0001555_218 / 0 / 18
hsa-miR-629-3pMIMAT0003298 0.0e+0 6.7e-3Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis.
Cancer Cell. 2014 Nov 10;26(5):707-721. doi: 10.1016/j.ccell.2014.09.005. Epub 2014 Oct 23.		MIPF0001555_218 / 0 / 18
hsa-miR-629-3pMIMAT0003298 0.0e+0 4.2e-1Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma.
Sci Rep. 2016 Dec 8;6:38750. doi: 10.1038/srep38750.		MIPF0001555_218 / 0 / 18
hsa-miR-629-3pMIMAT0003298 4.6e-5 0.0e+0Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.
Blood Adv. 2017 May 16;1(13):812-823. doi: 10.1182/bloodadvances.2016003251. eCollection 2017 May 23.		MIPF0001555_218 / 0 / 18
hsa-miR-629-3pMIMAT0003298 1.8e-2 1.8e-2Replenishing exosomes from older bone marrow stromal cells with miR-340 inhibits myeloma-related angiogenesis.
Blood Adv. 2017 May 16;1(13):812-823. doi: 10.1182/bloodadvances.2016003251. eCollection 2017 May 23.		MIPF0001555_218 / 0 / 18
[1]